Silicon-Containing Thiol-Specific Bioconjugating Reagent
Covalent Modifiers
JANUARY 24, 2024
The resulting conjugates display good stability in the presence of various biomolecules, which suggests their potential application for the synthesis of antibody–drug conjugates. Furthermore, the presence of a silicon moiety within the conjugated products opens up new avenues for drug release and bridging inorganics with other disciplines.
68 
Let's personalize your content